Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy

Metabolism: Clinical and Experimental

Volumn 54, Issue 12, 2005, Pages 1669-1678

  Jazet, Ingrid M ^a   Ouwens, D Margriet ^a   Schaart, Gert ^b   Pijl, Hanno ^a   Keizer, Hans ^b   Maassen, J Antonie ^a   Meinders, A Edo ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; DEUTERIUM; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; ORAL ANTIDIABETIC AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRIACYLGLYCEROL;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; INSULIN TREATMENT; ISOTOPE LABELING; LOW CALORY DIET; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD36; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; ENERGY INTAKE; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PHOSPHOPROTEINS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 28444448040     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.06.017     Document Type: Article

References (47)

1. D.E. Kelley, R. Wing, and C. Buonocore Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 77 1993 1287 1293
2. R.R. Wing, E.H. Blair, and P. Bononi Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients Diabetes Care 17 1994 30 36
3. R.A. DeFronzo Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM Diabetes 37 1988 667 687
4. R.A. DeFronzo, E. Jacot, and E. Jequier The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization Diabetes 30 1981 1000 1007
5. G. Perseghin, K. Petersen, and G.I. Shulman Cellular mechanism of insulin resistance: potential links with inflammation Int J Obes Relat Metab Disord 27 Suppl 3 2003 S6 S11
6. J. Machann, H. Haring, and F. Schick Intramyocellular lipids and insulin resistance Diabetes Obes Metab 6 2004 239 248
7. A. Bonen, M.L. Parolin, and G.R. Steinberg Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36 FASEB J 18 2004 1144 1146
8. S.L. Coort, D.M. Hasselbaink, and D.P. Koonen Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats Diabetes 53 2004 1655 1663
9. D.J. Dean, J.T. Brozinick Jr, and S.W. Cushman Calorie restriction increases cell surface GLUT-4 in insulin-stimulated skeletal muscle Am J Physiol 275 1998 E957 E964
10. S.S. Bae, H. Cho, and J. Mu Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B J Biol Chem 278 2003 49530 49536
11. H. Cho, J. Mu, and J.K. Kim Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science 292 2001 1728 1731
12. C.E. McCurdy, R.T. Davidson, and G.D. Cartee Brief calorie restriction increases Akt2 phosphorylation in insulin-stimulated rat skeletal muscle Am J Physiol Endocrinol Metab 285 2003 E693 E700
13. I.M. Jazet, H. Pijl, and M. Frölich Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese type 2 diabetic patients Diabet Med 22 2005 52 55
14. I.M. Jazet, H. Pijl, and M. Frölich Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin Metabolism 54 2005 705 712
15. O.K. Faber, and C. Binder C-peptide response to glucagon. A test for the residual B-cell function in diabetes mellitus Diabetes 26 1977 605 610
16. Andersson BL, Bjorntorp P, Seidell JC. Measuring obesity-classification and description of anthropometric data. Report on a WHO consultation on epidemiology of obesity. Copenhagen. Nutrition Unit, WHO Regional Office for Europe; EUR/ICP/NUT. 125, 1-22. 1988.
17. O. Hother-Nielsen, and H. Beck-Nielsen On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion Diabetologia 33 1990 603 610
18. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
19. H. Reinauer, F.A. Gries, and A. Hubinger Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers J Clin Chem Clin Biochem 28 1990 505 511
20. M.T. Ackermans, A.F. Ruiter, and E. Endert Determination of glycerol concentrations and glycerol isotopic enrichments in human plasma by gas chromatography/mass spectrometry Anal Biochem 258 1998 80 86
21. J. Bergstrom Percutaneous needle biopsy of skeletal muscle in physiological and clinical research Scand J Clin Lab Invest 35 1975 609 616
22. D.M. Ouwens, G.C. van der Zon, and G.J. Pronk A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation J Biol Chem 269 1994 33116 33122
23. H.A. Keizer, G. Schaart, and N.N. Tandon Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres Histochem Cell Biol 121 2004 101 107
24. L.B. Borghouts, G. Schaart, and M.K. Hesselink GLUT-4 expression is not consistently higher in type-1 than in type-2 fibres of rat and human vastus lateralis muscles; an immunohistochemical study Pflugers Arch 441 2000 351 358
25. M. Cho, S.G. Webster, and H.M. Blau Evidence for myoblast-extrinsic regulation of slow myosin heavy chain expression during muscle fiber formation in embryonic development J Cell Biol 121 1993 795 810
26. R. Koopman, G. Schaart, and M.K. Hesselink Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids Histochem Cell Biol 116 2001 63 68
27. L.J.C. Van Loon, V.B. Schrauwen-Hinderling, and R. Koopman Influence of prolonged endurance cycling and recovery diet on intramuscular triglyceride content in trained males Am J Physiol Endocrinol Metab 285 2003 804 811
28. R. Steele Influences of glucose loading and of injected insulin on hepatic glucose output Ann NY Acad Sci 82 1959 420 430
29. P. Schrauwen, V. Hinderling, and M.K. Hesselink Etomoxir-induced increase in UCP3 supports a role of uncoupling protein 3 as a mitochondrial fatty acid anion exporter FASEB J 16 2002 1688 1690
30. M. Bjornholm, Y. Kawano, and M. Lehtihet Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation Diabetes 46 1997 524 527
31. A. Krook, M. Bjornholm, and D. Galuska Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients Diabetes 49 2000 284 292
32. K. Cusi, K. Maezono, and A. Osman Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle J Clin Invest 105 2000 311 320
33. A. Krook, R.A. Roth, and X.J. Jiang Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects Diabetes 47 1998 1281 1286
34. Y.B. Kim, S.E. Nikoulina, and T.P. Ciaraldi Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes J Clin Invest 104 1999 733 741
35. A. Barthel, and D. Schmoll Novel concepts in insulin regulation of hepatic gluconeogenesis Am J Physiol Endocrinol Metab 285 2003 E685 E692
36. D. Cameron-Smith, L.M. Burke, and D.J. Angus A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle Am J Clin Nutr 77 2003 313 318
37. R.J. Tunstall, K.A. Mehan, and G.D. Wadley Exercise training increases lipid metabolism gene expression in human skeletal muscle Am J Physiol Endocrinol Metab 283 2002 E66 E72
38. B. Vistisen, K. Roepstorff, and C. Roepstorff Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers J Lipid Res 45 2004 603 609
39. A. Bonen, J.J. Luiken, and S. Liu Palmitate transport and fatty acid transporters in red and white muscles Am J Physiol 275 1998 E471 E478
40. K.J. McCullagh, C. Juel, and M. O'Brien Chronic muscle stimulation increases l lactate transport in rat skeletal muscle Mol Cell Biochem 156 1996 51 57
41. J.J. Luiken, D.P. Koonen, and J. Willems Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36 Diabetes 51 1999 3113 3119
42. Y.B. Kim, J.S. Zhu, and J.R. Zierath Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle Diabetes 48 1999 310 320
43. T.G. Kurowski, Y. Lin, and Z. Luo Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle Diabetes 48 1999 658 663
44. J.F. Wojtaszewski, B.F. Hansen, and J. Gade Insulin signaling and insulin sensitivity after exercise in human skeletal muscle Diabetes 49 2000 325 331
45. A. Dunaif, X. Wu, and A. Lee Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS) Am J Physiol Endocrinol Metab 281 2001 E392 E399
46. M.S. Hickey, C.J. Tanner, and D.S. O'Neill Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo J Appl Physiol 83 1997 718 722
47. A.R. Gosmanov, G.E. Umpierrez, and A.H. Karabell Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes Am J Physiol Endocrinol Metab 287 2004 E8 E15